“Transforming and improving patient lives should be the defining purpose, with patients at the core of every endeavor.” – Amir Heshmatpur (Executive Chairman , NeOnc Technologies Holdings)
(Isstories Editorial):- New York City, New York Mar 27, 2025 (Issuewire.com) – Healthcare 360 Magazine, a premier B2B publication, has spotlighted NeOnc Technologies Holdings in its recent issue, highlighting the company’s groundbreaking work in overcoming the blood-brain barrier for transformative CNS therapies. This feature underscores NeOnc’s pivotal role in pioneering advanced drug delivery solutions.
More on Isstories:
- CapitalTech Launches Revenue-Sharing Tokens as a New Household Income Asset
- Hansen Surf: Hub for Surf and snow gear top surf brands, including Obermeyer, Vissla, spyder in Encinitas, San Diego, CA
- Catch the Wave at Hansen Surf Store: Your Ultimate surf gear Surfboard Destination in Encinitas, San diego California
- Hansen’s Surf Shop Billabong, Roxy, O’Neill, Rip Curl, Rhythm womens dresses skirts snow gear Encinitas, San Diego CA
- SEEQUR Exposes India’s Hidden “Expert Gap”
This issue, Trailblazers in Healthcare Innovation: NASDAQ Visionaries 2025, explores groundbreaking advancements in overcoming the blood-brain barrier (BBB) to enhance drug delivery. It highlights the innovative efforts of companies and researchers developing new strategies to deliver therapies to the central nervous system (CNS), transforming the treatment of neurological disorders.
About NeOnc technologies Holdings
Founded by Dr. Chen, whose expertise in oncology and neuroscience fueled groundbreaking research at USC Keck Medical School, NeOnc Technologies strives to solve the blood-brain barrier challenge. This mission, aimed at developing life-changing CNS treatments, remains the company’s driving force.
What Readers Can Learn from the Cover Story?
- The platform overcomes the blood-brain barrier, improving drug delivery effectiveness for treating brain disorders.
- NeOnc collaborates with academic institutions and pharmaceutical companies to expand its use for a broader range of CNS conditions beyond brain cancer.
- Amir Heshmatpur’s leadership has driven the company’s success, including advancing clinical trials and securing over 135 patents worldwide
- NeOnc Technologies is leading the way in non-invasive, and precision drug delivery.
About Healthcare 360 Magazine
Dedicated to transforming healthcare understanding, Healthcare 360 Magazine provides a dynamic, global digital space for innovation and inspiration. It delivers cutting-edge information and success stories, empowering healthcare professionals and individuals with transformative ideas.
Healthcare 360 Magazine
[email protected]
+1 (408) 520-9503
https://healthcare360magazine.com/
This article was originally published by IssueWire. Read the original article here.
